AYAlla V. Yegorova

Alla V. Yegorova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alla V. Yegorova has a total of 82 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    VALIDATION OF HPLC METHOD FOR THE DETERMINATION OF RIVAROXABAN FOR COMPARATIVE EXTRACTION IN STUDYING THE DELIVERY OF THE DRUG VIA NASOGASTRIC TUBE IN VITRO.

    by Yu. Skrypynets, A. Yegorova, I. Chebotarska, D. Aleksandrova, O.V. Sysenko, S. Kashutskуy

    A new coordination compound of Ni(II) with cyclohexylacetoacetate and N,N-diethylnicotinamide was synthesized and characterized by IR spectroscopy and X-ray analysis. The IR spect­rum exhibits intense broad absorption bands corresponding to the stretching vibrations of the C=O and C=C bonds conjugated within the chelate ring (1625, 1502 cm⁻¹), as well as other absorption bands characteristic of β-dicarbonyl complexes, in particular a sharp band at 775 cm⁻¹ attributed to the out-of-plane bending vibration of the C–H bond in the chelate ring. In the high-frequency region of the spectrum, there are signals of stretching vibrations of the C-H bonds of alkyl groups (2855–2990 cm–1) and weak signals of stretching vibrations of the C-H of the pyridine ring (3080–3110 cm–1). The absorption bands of the amide group (νС=О 1620–1650 cm–1) and the pyridine ring (νС=С, νС=N 1500–1600 cm–1) of N,N‑diethylnicotinamide overlap with the vibration bands of the chelate rings and cannot be unambiguously assigned. The medium-intensity band at 1300 cm⁻¹, present in both the free ligand and the complex, is assigned to C–N stretching vibrations of the amide group. The low-intensity bands in the 600–400 cm⁻¹ region are assigned to Ni–N and Ni–O vibrations. According to X-ray data, the crystal system of NiL2NK2 complex is monoclinic, space group P21/с, a = 7.0360(15) Å, b = 13.233(4) Å, c = 23.619(5) Å, α = γ = 90º, β = 93.301(12)º. The structure corresponds to the formula [Ni(C10H15O3)2(C10H14N2O)2] and represents a mononuclear complex located in a special position relative to the inversion center. The cent­ral Ni atom has a O4N2 distorted octahedral environment. The axial positions of the coordination polyhedron are occupied by the nitrogen atoms of the pyridine ring of N,N‑diethylnicotinamide. The molecules of chelating ligands, coordinated through oxygen atoms, occupy an equatorial position with a trans configuration relative to each other. In the crystal, the complex molecules are bound by weak C-H…π interactions and form layers in the (001) plane, alternating with each other. The structure of the coordination polyhedron of the described compound is similar to the structure of adducts of β-dicarbonyl complexes of d‑metals with pyridine.

  • Open Access

    VALIDATION OF HPLC METHOD FOR COMPARATIVE STABILITY DETERMINATION IN STUDYING THE DELIVERY OF THE DRUG TICAGRELOR VIA NASOGASTRIC TUBE (in vitro)

    by A. V. Yegorova, Yu. V. Skrypynets, I. I. Chebotarska, D. I. Aleksandrova, N. M. Sukhostavska, G. V. Kiriiak, S. N. Kashutskyy, Ю. В. Скрипинець

    Enteral administration of drugs via a tube is the preferred method for patients who cannot swallow safely. Factors that may lead to tube blockage and reduced drug efficiency should be considered. Therefore, it is necessary to demonstrate that the generic drug is therapeutically equivalent to the reference drug when administered via a nasogastric tube. To monitor the stability of drugs after suspension of crushed tablets in a proposed medium and delivery via a nasogastric tube, the determination of related substances is performed. In this work, the drug ticagrylor was studied, which is an antiplatelet agent and reduces the process of platelet activation. This drug is often administered through nasogastric tubes. A method for the determination of related substances by HPLC with UV detection has been validated, suitable for monitoring the stability of the drug Ticagrelor IC, film-coated tablets, 90 mg, when passing through a NG tube. The method was validated for the following criteria: specificity, linearity, accuracy, precision, limit of detection, limit of quantification, robustness and stability of solutions. In our developed method there is no need to use special chemical reagents, high percentage of organic solvent, high flow rate, additional guard column. Chromatographic system consists of ODS column (150 mm × 4.6 mm × 1.8 μm). Mobile phase A was prepared by mixing a solution of 156 g / L NaH2PO4: water: acetonitrile (1:89:10), mobile phase B was prepared by mixing a solution of 156 g / L NaH2PO4: water: acetonitrile (1:29:70), gradient was used; flow rate 1.0 ml / min, detection wavelength 242 nm, using an injection volume of 5 μl. The linearity of the method for supernatural houses was assessed in the concentration range of 50–150%. The concentration of 0.9 μg/mL was selected as the 100% point, which corresponds to 0.2%. The method demonstrated satisfactory regression linearity (0.99999) with a good repeatability range (1.68–1.84%) with LOD and LOQ; 0.52% and 1.57%, respectively. The standardization of the content of identified and unidentified impurities is established in accordance with the requirements of the ICH Q3B guideline.

  • Open Access

    Validation of the Spectrophotometric Method for the Determination of Favipiravir for the Quality Control of Tablets

    by Yu.V. Scrypynets, I.I. Chebotarska, D.I. Aleksandrova, S.N. Kashutskуy, Odesa Іnterchem, A.V. Yegorova

    Pharmaceutical development is a mandatory component of the technological regu-lations and the registration dossier for a medicinal product. Establishing the methodological foundations for quality control and the physicochemical properties of medicines is a crucial task for the introduction and production of high-quality, effective, and safe pharmaceuticals. A reasoned choice of methods for the analysis of dosage forms allows for the optimization of the quality control system at a pharmaceutical enterprise and en-sures the economic efficiency of control and measuring equipment usage. The most important characteristic of a medicinal product is its quality. Quality control of medicinal substances and dosage forms is regulated by the relevant monographs of the State Pharmacopoeia of Ukraine or Europe. Therefore, the development and introduction into production of domestic drugs that meet the established quality requirements is a timely task for the fields of medicine and pharmacy. The spectrophotometric method for the test "Assay" of the drug Favipiravir, film-coated tablets, 200 mg, was validated. A systematic study of its chemical-analytical and metrological parameters was conducted. The method was validated according to the in-dicators of specificity, accuracy, precision, and linearity in the studied concentration range, in accordance with the requirements of the State Pharmacopoeia of Ukraine.

  • Open Access

    DETERMINATION OF THE IONIZATION CONSTANT OF FAVIPIRAVIR API

    by Yu. V. Scrypynets, G. O. Fedosenko, G. V. Maltsev, I. I. Chebotars'Ka, D. I. Aleksandrova, S. N. Kashutskуy, A. V. Yegorova

    За даними кислотно-основного титрування була визначена константа іонізації АФІ фавіпіравіру: рKa = 5.05 ± 0.02. На підставі знайденого значення рKa були розраховані ступені утворення протолітічних форм в залежності від рН розчину. Встановлено, що АФІ фавіпіравіру в розчинах існує в двох протонованих (неіонізованих), таутомерних формах А1Н та А2Н і одній депротонованій (іонізованій) формі А-. На етапі фармацевтичної розробки ці дані по кислотно-основним властивостям АФІ фавіпіравіру можуть бути використані при розробці технології виробництва, створення методик контролю якості та їх валідації, а також при вивченні розчинності АФІ та профілів розчинення готового лікарського засобу.

  • Open Access

    A New Fluorescent Probe Based on N-(2-carboxymethyl)benzoaza-15-crown-5 for Sensitive and Selective Determination of Cu2+

    by A.V. Bogatsky Physico-Chemical Institute of the National Academy of Sciences of Ukraine, A.V. Yegorova, Yu.V. Skrypynets, I.I. Leonenko, D.I. Aleksandrova, T.I. Kirichenko, S.S. Basok, C.Yu. Kulygina

    Copper is widely used and therefore it is a pollutant metal. It is important to develop probes that can selectively determine copper with high sensitivity. The benzoaza-15-crown-5 derivatives are used as fluorescence sensing systems and excellent spectroscopic properties are demonstrated. The “N”, “O” atoms of the heterocyclic unit act as binding sites for recognizing copper ions. A new, simple, sensitive fluorescence method for the determination of Cu2+ ions was developed and analytical characteristics of the proposed probe were estimated. The Cu2+ ions can significantly quench the fluorescence intensity of N-(2-carboxymethyl)benzoaza-15-crown-5 (Cr) in ethanol/H2O (4:6, v/v) solvent mix containing urotropine buffer (pH 7.5) at λex = 274 nm and λem = 308 nm. The probe has high photostability. Under optimal conditions, the quenching of fluorescence intensity depends on the concentration of Cu2+ ions in the range of 1.70 × 10-6 - 2.38 × 10-4 М, detection limit was 0.56 μМ. This method was applied for the determination of Cu2+ ions in drinking water. The quenching effect in the presence of copper (II) can be explained by the termination of intramolecular charge transfer from the chelate center to the aromatic part of the molecule due to chelation.

  • Practical application of high-performance liquid chromatography and high-performance thin-layer chromatography in pharmaceutical analysis.

    by A. V. Bogatsky Physico-Chemical Institute of the National Academy of Sciences of Ukraine, A. Yegorova, Yu Scrypynets, G Fedosenko, InterChem SLC, G Maltsev, S Kashutskiy

    Currently, chromatographic methods are widely used to control the quality of products in the pharmaceutical and food industries. This article is devoted to the systematization of the results of scientific research of the authors on the development, validation and application of a number of chromatographic methods in the creation of generic drugs, as well as in the analysis of medicinal plant materials. The developed methods are validated according to the following parameters: specificity, linearity, accuracy and limit of detection. The specificity of the methods is based on the ability to evaluate the analyte in the presence of other components and is confirmed by using external standards. The accuracy was assessed by the results of the analysis of different weights or by the "added-found" method. For the developed methods, parameters of the suitability of chromatographic systems were established (peak symmetry factor, number of theoretical plates, relative standard deviation of retention time and peak area).

  • LUMINESCENT DETERMINATION OF FAVIPIRAVIR USING THE EUROPIUM (III) COMPLEX

    by Yu.V. Scrypynets, A.V Yegorova, І.і. Leonenko, O.D. Voitiuk, Ю.в. Скрипинець, А.в. Єгорова

    Of particular interest in recent years is the possibility of analytical application not only of the effects of sensitizing the luminescence of lanthanide ions, but also its quenching or increase for the indirect determination of a number of drugs. Favipiravir (FAV) - 6-fluoro-3-hydroxypyrazine-2-carboxamide - is an oral antiviral drug approved for the treatment of influenza in Japan. This drug is an analogue of purine nucleosides, which acts as a competitive inhibitor of RNA polymerase required for virus replication. Favipiravir is capable of forming a complex compound with Eu(III) ions, in which due to intramolecular transfer of excitation energy from the organic ligand to the Eu(III) ion there is a very slight sensitized luminescence of the latter due to dissipation of excitation energy from the triplet level (24390 cm-1), which cannot be used for analytical purposes. The influence of some surfactants and donor-active substances on the Ilum of the Eu(III) –FAV complex is considered. It was found that only batophenanthroline (BPh) significantly increases the luminescence intensity (Ilum) of the Eu(III)–FAV complex, approximately 10 times, due to more efficient intramolecular energy transfer from batophenanthroline (18100 cm-1) to the level of europium ions (17300 cm-1). A synergistic effect has been established, which is manifested in the combined action of two complexes (Eu(III)–BPh and Eu(III)–FAV) and exceeds the sum of the Ilum of each of them separately. The synergism is caused by formation of a multiligand complex. It was established that a mixed ligand complex Eu(III)–BPh–FAV (1:1:1) is formed. The possibility of using the complex compound Eu(III)-BPh as a new luminescent probe for the determination of favipivir has been shown. The luminescence intensity is maximum at pH 7.5 (urotropin buffer). The excitation band λexc = 315 nm was chosen for analytical purposes. It was found that the introduction of different amounts of favipiravir into aqueous solutions of the Eu(III)-BPh complex causes an increase in 4f-luminescence of europium (III) (transition 5D0 → 7F2, λemis = 615 nm) and the lifetime of its excited state. Calibration curve was linear over the concentration range of favipivir 0.5-10.0 μg/ml. The developed method is validated by the following parameters: specificity, linearity, accuracy, limit of quantitative determination. The proposed method is characterized by satisfactory metrological characteristics and ease of implementation and can be recommended for the determination of FAV in tablets.

  • Determination of Sodium Metamizole by High Performance Liquid Chromatography Taking into Account its Decomposition in Aqueous Solutions in the Study of Dissolution Profiles

    by A. V. Yegorova, G. V. Mal’TSev, Yu. V. Skripinets, O. D. Voityuk, S. N. Kashutskii, I. V. Umetskaya, V. P. Antonovich

    A procedure for the quantitative HPLC determination of sodium metamizole is developed and validated to study dissolution profiles of the PENTALGIN IC® medicinal preparation, tablets, taking into account the decomposition of sodium metamizole in aqueous solutions. In the study of dissolution profiles, along with the release of sodium metamizole from the finished dosage form, its hydrolysis to the decomposition product, methylaminophenazone, occurs. The decomposition reaction is unimolecular; therefore, the chromatograms of the test and reference solutions have two peaks, corresponding to metamizole and methylaminophenazone. It is shown that, for the correct calculation of the amount of sodium metamizole passed to the solution from the tablet, one should determine it from the sum of areas of both peaks, taking into account detector response factors.


  • Determination of curcumin in bouillon cubes by high-performance thin-layer chromatography

    by A. V. Bogatsky Physico-Chemical Institute of the National Academy of Sciences of Ukraine, A Yegorova, Yu Loskutova, InterChem SLC, G Voitiuk, A Maltsev, E Malinka, Odessa National Academy Of Food Technologies, Yu Scrypynets

    Currently, high-performance thin-layer chromatography (HPTLC) is widely used to control product quality in the pharmaceutical and food industries. In the manufacture of food products, the most important requirement is the control of the content of various additives (preservatives, dyes, antioxidants). For the first time, a method for determining curcumin by high-performance thin-layer chromatography in bouillon cubes "Gallina Blanca" was proposed. Detection was carried out by densitometric scanning using CAMAG equipment when measuring absorbance at a wavelength 265 nm. The method is based on determining the peak area of curcumin in the chromatogram depending on its concentration. Curcumin content is determined by the calibration curve. The developed method was validated by the following tests: specificity, linearity, accuracy and detection limit. The calibration curve is linear in the range of curcumin concentrations from 120 to 520 ng/spot, the detection limit is 65 ng/spot. The specificity of the method is based on the ability to unambiguously evaluate the analyte in the presence of other components and is confirmed by using an external standard. The spots on the chromatograms of the test solution and the reference solution coincide in the value of Rf, which confirms the specificity of the method. Accuracy was evaluated according to the results of the analysis of various samples. The requirement for statistical insignificance of systematic error is fulfilled. The proposed method is express, characterized by satisfactory metrological characteristics, ease of implementation. Key words: high-performance thin-layer chromatography, curcumin, validation.


  • Open Access

    Development and Validation of HPLC-MS Method of Determination of Memantine Hydrochloride for Study of Dissolution Profiles

    by A. Yegorova, Yu. Skrypynets, I. Leonenko, G. Maltsev, S. Kashutskуy, O. Voitiuk

    A method for quantitative determination of memantine hydrochloride by HPLC with mass spectrometric detection (HPLC-MS), suitable for the study of dissolution profiles of tablets "Mematon IС" was developed. Chromatographic determination was performed using a mobile phase of methanol - 0.1% (v/v) aqueous solution of formic acid (55:45) on a column of Zorbax Eclipse Plus C18 size 10 cm Ч 4.6 mm (3.5 μm) at a flow rate of 1 ml/min. The linearity interval in the appropriate dissolution media is 35 - 150 % of the normalized content of memantine hydrochloride in the tablet. The method is validated on the parameters of specificity, accuracy, correctness, linearity in the studied range of concentrations, robustness. The stability of the tested solutions and reference solutions in the case of their storage at room temperature for 24 hours was confirmed. It is established that in the case of the study of solutions prepared in a dissolution medium of 0.1 M hydrochloric acid solution pH 1.2, there is a need to preneutralize hydrochloric acid before analysis, because it, as stronger than formic acid, almost completely ionizes all dissolved molecules, which leads to a significant deviation of the linear dependence of the analytical signal on the concentration of the analyte. Neutralization is performed with 0.1 M sodium hydroxide solution, which is added to the sample of the test solution. The release of more than 85 % of memantine hydrochloride in 15 min in all dissolution media indicates the similarity of the dissolution profiles and does not require the calculation of the similarity factor f2.